Kraig Biocraft Laboratories' Spider Silk Production Efficiency Doubles
March 24 2014 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the
leading developer of advanced spider silk based fibers, announced
today that its genetically engineered spider silk, Monster Silk™,
production program has more than doubled in productivity.
During the pilot production program, the yield rate of viable
silk cocoons was approximately 30%. At those rates, the cost
structure warranted the conversion of the pilot test program to a
much larger scale.
The latest reports from the current production ramp up point to
a dramatic and unexpected increase in yield to 70%; more than
double the output efficiency shown during the pilot phase.
The initial assessment from the Company's scientific team is
that the Monster Silkworms™ are acclimating to the production
environment.
"This dramatic boost in productivity was a surprise to us. Our
plan was to methodically increase productivity rates over the next
18 months. Our team had drawn up plans that included selective
breeding and cross breeding to achieve those goals. To see such a
remarkable gain in so short a time was beyond our expectations. The
obvious benefits, should these rates continue, would include
reduced production costs and reduced ramp up time," said Company
Founder and CEO, Kim K. Thompson.
"With this doubling in efficiency, we need to focus on emplacing
the necessary infrastructure to support the increased
productivity. As far as challenges go, these are good problems
to have. We have already taken action to beef up our
production infrastructure to support these larger numbers. The
improvement in performance is dramatic; but, with such significant
advancements I am cautious until I see that results are consistent
over the next few months," Thompson concluded.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Apr 2023 to Apr 2024